Tharimmune, Inc.
THAR
$2.97
-$0.03-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.10% | 20.20% | 2.48% | 6.94% | 3.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.13% | 39.01% | 31.50% | 27.93% | 1.38% |
| Operating Income | -33.13% | -39.01% | -31.50% | -27.93% | -1.38% |
| Income Before Tax | -35.36% | -40.47% | -30.89% | -26.00% | 0.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.36% | -40.47% | -30.89% | -26.00% | 0.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.36% | -40.47% | -30.89% | -26.00% | 0.49% |
| EBIT | -33.13% | -39.01% | -31.50% | -27.93% | -1.38% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 88.70% | 92.36% | 94.96% | 92.34% | 79.31% |
| Normalized Basic EPS | 88.70% | 92.36% | 94.96% | 92.34% | 79.31% |
| EPS Diluted | 88.70% | 92.36% | 94.96% | 92.34% | 79.31% |
| Normalized Diluted EPS | 88.70% | 92.36% | 94.96% | 92.34% | 79.31% |
| Average Basic Shares Outstanding | 313.25% | 468.46% | 1,367.18% | 2,277.97% | 1,450.18% |
| Average Diluted Shares Outstanding | 313.25% | 468.46% | 1,367.18% | 2,277.97% | 1,450.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |